The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study
Launched by ERZINCAN BINALI YILDIRIM UNIVERSITESI · Mar 11, 2025
Trial Information
Current as of July 31, 2025
Completed
Keywords
ClinConnect Summary
Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be on hemodialysis treatment for at least 6 months,
- • No sleeping pills or sedative medication,
- • No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness,
- • The patient or someone living in the same household with the patient is literate,
- • Patients have no vision problems,
- • Patients must be 18 years of age or older.
- Exclusion Criteria:
- • Being on hemodialysis treatment for less than 6 months,
- • Taking sleeping pills or sedative medication,
- • Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided,
- • Illiteracy of the patient and relatives,
- • Patients have vision problems,
- • Refusing to participate in the research,
- • Under 18 years of age
About Erzincan Binali Yildirim Universitesi
Erzincan Binali Yildirim University is a prominent academic institution dedicated to advancing knowledge and research in the field of health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research initiatives aimed at improving patient care and outcomes. With a commitment to ethical standards and rigorous scientific methodology, Erzincan Binali Yildirim University collaborates with healthcare professionals and researchers to conduct clinical trials that contribute to the understanding of various medical conditions and the development of new therapeutic approaches. Through these efforts, the university plays a vital role in the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elazığ, Merkez, Turkey
Patients applied
Trial Officials
Gülcan Bahçecioğlu Turan, Associate Professor
Principal Investigator
Firat University
Zülfünaz Özer, Associate Professor
Study Director
Istanbul Sebahattin Zaim University
Safiye Yanmış, Assistant Professor
Study Director
Erzincan Binali Yildirim Universitesi
Mukadder Mollaoğlu, Professor Doctor
Study Director
Cumhuriyet University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported